Rockville-based Human Genome Sciences
has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline
Human Genome, which employs about 1,000 people in Rockville, could not be reached for comment Wednesday. But it told the state Department of Labor, Licensing and Regulation that the layoffs — to start Oct. 30 — were part of an internal restructuring.
GlaxoSmithKline, a London pharmaceutical firm, also could not immediately be reached for comment.
Text BUSINESS to 70701 to get Baltimore Sun Business text alerts
We've upgraded our reader commenting system. Learn more
about the new features.
The Baltimore Sun encourages civil dialogue related to our stories; you must register and log-in to our site in order to participate. We reserve the right to remove any user and to delete comments that violate our Terms of Service
. By commenting, you agree to these terms. Please flag inappropriate comments.